I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase III study of dulanermin (recombinant human tumor necr..:
Ouyang, Xuenong
;
Shi, Meiqi
;
Jie, Fangwei
...
Investigational New Drugs. 36 (2017) 2 - p. 315-322 , 2017
Link:
https://doi.org/10.1007/s10637-017-0536-y
RT Journal T1
Phase III study of dulanermin (recombinant human tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand) combined with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s10637-017-0536-y&Exemplar=1&LAN=DE A1 Ouyang, Xuenong A1 Shi, Meiqi A1 Jie, Fangwei A1 Bai, Yuxian A1 Shen, Peng A1 Yu, Zhuang A1 Wang, Xiuwen A1 Huang, Cheng A1 Tao, Min A1 Wang, Zhehai A1 Xie, Conghua A1 Wu, Qi A1 Shu, Yongqian A1 Han, Baohui A1 Zhang, Fengchun A1 Zhang, Yiping A1 Hu, Chunhong A1 Ma, Xitao A1 Liang, Yongjie A1 Wang, Anlan A1 Lu, Bing A1 Shi, Yi A1 Chen, Jinfei A1 Zhuang, Zhixiang A1 Wang, Jiejun A1 Huang, Jianjin A1 Wang, Changhui A1 Bai, Chunxue A1 Zhou, Xin A1 Li, Qiang PB Springer Science and Business Media LLC YR 2017 SN 0167-6997 SN 1573-0646 JF Investigational New Drugs VO 36 IS 2 SP 315 OP 322 LK http://dx.doi.org/https://doi.org/10.1007/s10637-017-0536-y DO https://doi.org/10.1007/s10637-017-0536-y SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)